EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Pharmacokinetics and safety of nafamostat and its metabolites following single- and multiple-dose oral administration of nafamostat mesylate in healthy male participants

Jun Ki Hong iD, Hyun Chul Kim iD, In-Jin Jang iD, SeungHwan Lee iD

Translational and Clinical Pharmacology · 2026 · 34 (2) · 88

DOI: 10.12793/tcp.2026.34.e7 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Translational and Clinical Pharmacology, 2026. Verfasst von Jun Ki Hong und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Pharmacology and Therapeutics, Seoul National University Hospital, Seoul National University College of Medicine, Seoul 03080,…. Die Arbeit nennt 25 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

Stichwörter der Autor:innen

NafamostatOral AdministrationPharmacokineticsSafety

Autor:innen und Institutionen

  • Department of Clinical Pharmacology and Therapeutics, Seoul National University Hospital, Seoul National University College of Medicine, Seoul 03080, Korea.

ORCID-Profile: Jun Ki Hong, Hyun Chul Kim, In-Jin Jang, SeungHwan Lee

Zitieren

APA

Hong, J. K., Kim, H. C., Jang, I. J., & Lee, S. (2026). Pharmacokinetics and safety of nafamostat and its metabolites following single- and multiple-dose oral administration of nafamostat mesylate in healthy male participants. Translational and Clinical Pharmacology, 34(2), 88. https://doi.org/10.12793/tcp.2026.34.e7

Vancouver

Hong JK, Kim HC, Jang IJ, Lee S. Pharmacokinetics and safety of nafamostat and its metabolites following single- and multiple-dose oral administration of nafamostat mesylate in healthy male participants. Translational and Clinical Pharmacology. 2026;34(2):88. doi:10.12793/tcp.2026.34.e7

BibTeX
@article{Hong2026,
  author = {Hong, Jun Ki and Kim, Hyun Chul and Jang, In-Jin and Lee, SeungHwan},
  title = {Pharmacokinetics and safety of nafamostat and its metabolites following single- and multiple-dose oral administration of nafamostat mesylate in healthy male participants},
  journal = {Translational and Clinical Pharmacology},
  year = {2026},
  volume = {34},
  number = {2},
  pages = {88},
  doi = {10.12793/tcp.2026.34.e7}
}
Kostenlos starten →